Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01582425 · ClinicalTrials.gov registry record · Phase 1
Drug Interaction Study of Isavuconazole and Methadone
A Phase 1 study, sponsored by Astellas Pharma Global Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01582425 is a Phase 1 study that has completed, run by Astellas Pharma Global Development. The registered enrollment target is 24 participants.
The verdict
NCT01582425, a Phase 1 study, has completed, sponsored by Astellas Pharma Global Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics (PK) of methadone after single dose administration. The secondary purpose is to assess the safety and tolerability of isavuconazole alone and in combination with methadone.
Interventions
- DRUG Methadone
- DRUG Isavuconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01582425
The ClinicalTrials.gov registry entry for NCT01582425 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma Global Development, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT01582425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01582425 about?
NCT01582425 is a clinical study titled "Drug Interaction Study of Isavuconazole and Methadone". The primary purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics (PK) of methadone after single dose administration. The secondary purpose is to assess the safety and tolerability of isavuconazole alone and in combination with methadone.
What is the current status of trial NCT01582425?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2012-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01582425?
The interventions under investigation include: Methadone (DRUG), Isavuconazole (DRUG).
Who is sponsoring clinical trial NCT01582425?
This trial is sponsored by Astellas Pharma Global Development, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.